Dexcom hit with legal fees in AgaMatrix patent spat
Dexcom (NSDQ:DXCM) this week was ordered to pay attorney’s fees in a spat with rival AgaMatrix over patents related to continuous glucose monitoring technology.
The ruling came alongside a final judgement of non-infringement in favor of AgaMatrix from Judge S. James Otero of the US District Court for the Central District of California Western Division, according to court documents.
Read the whole story on our sister site, Drug Delivery Business
The post Dexcom hit with legal fees in AgaMatrix patent spat appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Fink Densford Tags: Diabetes Legal News AgaMatrix Inc. Dexcom Source Type: news